Discover millions of ebooks, audiobooks, and so much more with a free trial

Only $11.99/month after trial. Cancel anytime.

Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective
Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective
Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective
Ebook826 pages8 hours

Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective

Rating: 0 out of 5 stars

()

Read preview

About this ebook

Nanotechnology has revolutionized cancer diagnosis and therapy through targeted drug delivery. Advances in protein engineering and materials science have led to the development of nanocarriers (NCs), which have helped overcome the challenges faced during conventional cancer treatment. These nanocarriers serve as an efficient transport module for drugs. Nano-drug delivery has emerged as a promising technology that results in early detection and better treatment of various cancers. The approved nanoparticles currently used in cancer treatment strategies include liposomes, dendrimers, polyplexes, solid lipid nano-carriers, etc. These nanocarriers can potentially provide a quick, safe, and cost-effective method in cancer therapy and management.

This book presents thirteen chapters that cover cancer nanotherapeutics for various cancers. The reference covers lung, breast, cervical, ovarian, colon, prostate, and head and neck cancers. Each chapter reviews advanced data from existing and ongoing clinical research and major regulatory considerations. A list of scientific references for further reading supplements every chapter. Readers will be able to understand recent advances and challenges faced by researchers in cancer nanomedicine.

This reference book will greatly benefit undergraduate and postgraduate students, oncologists, pharmacists, and researchers involved in nanomedicine and nano-drug delivery.
LanguageEnglish
Release dateMar 6, 2023
ISBN9789815080506
Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective

Related to Therapeutic Nanocarriers in Cancer Treatment

Related ebooks

Medical For You

View More

Related articles

Reviews for Therapeutic Nanocarriers in Cancer Treatment

Rating: 0 out of 5 stars
0 ratings

0 ratings0 reviews

What did you think?

Tap to rate

Review must be at least 10 words

    Book preview

    Therapeutic Nanocarriers in Cancer Treatment - Neeraj Mishra

    ͣaebook_preview_excerpt.html}rvT8aP"ERRw DIDAR2 =PI*t]HO {G^ŰUyݹiy槦r'z3M˹*&}3{^&==\?y͟s_Gߏe|Vi\:m?(y[ņ(oGdUm*eZfo"]R~pj?mi\bIm~]UԞO1, TUR3gem׺K.iJk9vus~.$Wqi=_&;gWod\,وX?2/EZi#&d.6Unn&*|˽unWlaohQ7Us-q˲??hҖʳt|I[|sRnvOU{rɥօOޚ^_"Ty$l1r&OnZe^uk~麣mb.AAD]k((miSj2?y4i5ϒ&y_T3%ڈ%'ARPoɜvц-}ytXBZU䱪1\=e"Y~oi/o5 uv5ת,gf Ɗ(xvi&'ZW&eH'%y%]U'4XR5wEtͫ蹭D4WTk8fe_mQ&p=,]ZmaXVu[ !`gg-к˻nN݊BO5{ɤD \0$W9}o l(b./p_1&7Ja|Bl1U_Xt8V7UR BۏMC:z$+1$ͳZ䮮V{%Ψ!|3/<')ݷv/3$^Պ7g'p nsF[)QM7uEpm3QWp2ٴ_$; ٔ-OXV*y菖F0£bhݬ 9t\xty%[E;\IbEFh*]vW=q=aU}W\Ls+>%i)&!{J}o1Uy%oA"$KW mg$ZŲYٛQX XC~]Sjoq)LGgDGluNR@1-6]}G 6Iء̕kUGl֭b"BsbLejϋ~son⣬bN=Q\rTAkB\i I?4aL]JW@?mfh&`gk0zʚNtT{#q"6mh%S34En"`ܖ&t.x,.kΨR,n;ca:wøb:E{*ˆ[D3G+c%oQKJρ-#\ۘRۤv#CpdJܧ kPZ{QK_ ceFu(xra㛶Z+@y=:%}YH'E-s,6UtѼԒ$ …Em1fG6ڐy٫L49 tgpFaRT[nٍ|˦tD,~hZWuzpMT+l}^MgU7f׎㬨 *`Ihf l3%o94FN7&)>qР[v 7 ˃iD$ NZX3^f `>áNZaWT+1 T$ʪb&aNhzXՉ|eظ7"&%PN@PL䒹 `E~kƐ̏Nl7t&}ZwEZyhKמ)-*O=xf l>ƕ_i l4p].m.b!KmnH[f>Wx]~U3́MCd3AlS q\^&A7l18*|RuC>3bRނն=7gv0'%;z VA/0LwJEJgS'" Kܲ g fyD RJVni/l:&Pfm:: tar ~t _ |vf"`UcU^Ș9챚"w^\ؕ^1$=Adv>zQ\"2)k—fLb)8d󌩌V񔕶dTu [| 兞Ѩ6sX qv°jT(Vr4?a~LL9:%tvaMNO.Oob4u@a\Yu)<;[9.N(*ު!oo82fʵ$B 3R:% ̽(̎W&ȫ&⬗y_@c @ h/yg2w -yE"0ƥ+j8 G*_y Q.ae- ݌wDM!\k?|`\YB!;V5 fzB>BhB{q-XNi+R*$1[1݁[7?oV?;R.?6KW:C( |:9KNade65H2J i6/L}zhL^6 0iSڔS' &%,P<ψZ=5m} #,-3*l:v".Md- ^@JZf`~]8ʣ`?d].eݖ@:Ԯ,x$e&P=禟N!ݰ~ݛi S(`w/::2nl!_u0=WHZt3:avzJOf<V =Æ.9N6v I5b Z}lK[ztP'PZe€%lN{KrA:fEMWLEP4tBs]F PTt‡ּۦߏʎH1+:è=)֘I:W*SQoZZ{hB7jalIC#lA,+BE"1Q6[AvȠ|pj {D9p"F@rm4@S4&AbχhX˂?ح.p<B8B % YҢoLf(Xy=l!,]wHO Gzhv-;4%,c̓Z#86ekNAXזx|PYqWts]OBǟdap8ǏE_ޯ!@0!FLx#s1LIpB:P(I1Pֹ$3RSq{ D ۧ^LiXc>UCy aF0q" Z1lVWzƔ Sg,nUӼ SLQ^bgC 5D0}̸p;~PՓ*P5Pʼ۟{խ7 x#QyK#U/3@j$J}2|%ʅȳِ @ZPˆHn [*)baPSNDnx^>Aކ3>N88jh8^pmZC>Dӧ2iL+(s Tv 4"籰N qw8<櫮CKvb*CT>n7 avoK4;fi!QD8烵W1%ei $Ύ0n>) <{ J ~o8Ê/w,8UMϕfaVIQa jh'3F~ LI-hvٖ۴;VxS.AL0 F=ARkB[03FYޱKqF=v(= zρ_,!> &&iS!srG~@+/kpƙX탏6֮%M,,suQQS$OW mJKU[E5 ˘d"/QL}R V8E.bG&M7T'MPnI-ì)dJ]sTaP[\KʲXT|slF-Y,`):oK<4HzжV@~tGe%JrshZ$_01 u%;l Qv^s*9R/fшU4 )P4K ]lf0bCpLHi& юo\N 0iVսUqA]ʜw%D Y6º#ambK>8h;Hq0} DpmWY"z v7.Ȟ#t]Pxq/r|@xn]h+V1$b Pٗ:sjphAT[~sr^${qƪ3ps^'+8*'4B3MZ?yؒ yI8 O*j\缌:Ӓ%Clሶ#eI飌%65έ#ScJckc<ȹa`J=ߘa rU̓{3 [@T0%4č䶆 Øwb7 .yČ2Ajل%.teߙH8`h_>nһ> pLEs[͉!留И3zW] hֈKv"sk|Ǵ[ōĨ>(3ag]~˵ xkXjOK܎/>K37gzRIThZuiݠ,b);%;`['ֹDp/xK"v1Sk' qAv| Nt>u0nm LtscE |DV![BjXZ;-bte/-0Ͷ0++Fa]>ƫH;P4[З{4`ω~xMMTgu= m 12,(;YQʾ<2b`&PJB GAM.qyuc9g2 {,D]-H=>{04@…tl4!%[j8VrsIFqzzJ$`W[;vlzEϛFU qmdEV|&B(/#+?%Dr?ƿ;Xʚuj$SNEJl"ѸSU(C||xl^=u8]xibE^DjsjǙ~'6DI"_viSX Q5Gh Y-^2C5B2IW{='Y-YlġYukFK ,Zp]1)}wmy_XD-_rU˧͗^bR7I4Fk֪^5OP(JcL$Q,G!0*X5iOtȼ~ ɽgŽ9qŹ'D;)v08'Y*ַ13&u!qK?"[ŲojIjQBj,;E:–iylB.vt ̼Y7Ŭ_dI 9ik9h\ԽQk.K_:;Rm;î6=LЯӬq% >=9qX(c>QYitHQvi6$ThnowQz5/X$h!*t-\86,ش$jf u\ZhVZ7#jٲ_5VgTMo^*GW,%6wD~,jFZ Vx WQ֚p6b$a?`ВTr;^Z6a& _pCQ.39btl37c͸#}oF+c/rD^\b!K ]7ӡ-*) Q)}s9t< :6-ʢF:h{9b%c 6~qFVӺO@}|t>x|N4*3=MB, 0a5cTjQ\6qq\ E`էvܑDjGu0GGRailLZu(%o^Te 1|}lu *e|JIH DŹFS}4Une4`(PC?ܹTbU&|yz8DX鉺%ɮ~I%$)<`芁w&aك_/d'Z%+Cm%C'zl$XG8;™j$y(,rzqBp8!kDOI).!jY =c\\+&䐘)Uc?9QD,Z hؔv{0 Rv0 RLc%&/  I5,emIn C{~ ?qhΛFdOQtP5E).~M~|"Nqz{p5'Z.p8\ۃ+{9QCg X1z^l hwȎ =8J0S+iU+:lܲ4wK ЍF[->{DMDDC@,bo9fE;Q@])iN&2U-w+ X4T 7_2S75U- 9HPP2੉#Op h}'l|BdţӲg]^+*$DT3MjUӒ0 yBZ6o7p##:*l_v=_uH_'E3nt2Dĥ87*|[=)9u!ēma&{4D4<4۠Q!3ӫ+U~H~arLN>>>yYpx$s=":!fxR$<*tU Ro&ˏ).]DbaGVK^Q-W/jɃZ w+҆c5+.S%̍N"']U8ce3#AE|@Ub r3=iM;[Ph9ZsbG\oQ|v50OE*&Py'f\# 5VļwC0\˵-$Fub.!zp5$gh2$9aW<+|I"_]\:xD7Zq?6Soj^SXF4,V4*GKX)m!;W%UʏJ.n )CJ8Yb\A!Ol~$(`R'.?&))K :ء7xoUqkQGCV)E? &}vO )wk/:icƎUhU;g']60ΣO?$;Tۯ mvC}o_kX p<lIb` (cZK{yV1r{M5,גx_<~ߡus2}+7XQAw\-Aũf@ ri@YyӀUǁ X)6 R\NGK|z7Jߟ\͢6o/_HWwuAIR 1Kzk|wLn`HoR]zYSyo<,pZV3LA=A6bA&Ƒn?2TkW5c փN=.-Я|: ˋ/\L}bʸrj?N>bhFM'u'ő˱, e7Bخy@ϊ:Eтble{5׌vǚ.z/8:dѯX4bxW4 :L^E_ ×//f#)B?C@+ 5ID6~K'mʻ(Yn҂Pg8;&#;0\l2LOX XdVOcbO1Jle1,r]N߿@aXIp+Ɍ`f8?. {}@JpG)Wh$|̓+;.B5xC_3j/iN@" ʬGSZѼOtǤrY^H ^:cz|~C\Xm:_!Jkgs+yX{T ;uvM/HN̏_"LmvwC`im竣` zs_J1?>8eɡ!ܫa0TxC" ACaf$UB!aAO_UXsЬy9KK7&_cicVxx&c8w%_+[Dbp(^J[U{tr5l$Y8&Xi(g)̚0W|xv" !P =7yzE NI\^a4y rfBt4ӿ78M'{~~uxBM'N>y yr0~:/Nڨ 8}{r9 "hCPA3 %\\|u>[. 7!xexery38ĹCHVc>]gHL]UP{tBeBL*l?Tmkp;tȍ >BwKfާPh'9-zngM|!>eSrQ6Ƣ~ ݖ#*_~(/5J#xb/w;"JE_VsʑVB5(TVO:T|2_s(4é Bv}% C(ێhg ij{oCz^("Dp#fb[8^nja3J[az~GXz\)@]9t^WQ[?hH,7)O,W>Ho'0 /$Jl.ZXE hM?v¶Z*g&p\+ώVeN0FLvZTh[6!mTl캊 KWR)! 5T,wP/nwjqYI\˪8v\5~HըyO8)Jk"r;f.O*]hOYLu|wε|U[Tey~o2Sŗ ^?ÍɹZUz]]^YӅ jXǧklʭ{o?[ZYsR\#FQBN(!#(TU]Xd9 km1L'T K*wP|zrx|M7,,![0Jʨ"|OCWj \\RE!<3؜7_릤?+LLJ8E%}g'oІG#g浊u7[dh-A-ҍe>[iG/87JOT=(n=3SPtfw(F& Hlj4>}\ ,9>p`7@7/Cm=AM)k7 _QNY6g˪;G}JČ!l.zLM&1 7=-vq 1+eox)+myWN+O"k8 0NF[1YAOMru&VG]!6x>#X)">{he,y B[AS`z7ZCw#gj;:b5nѰKFAbAAzp3I6};Mp(JI5\$޲B $TYUxkRB_?l)Ye:> 3ѩ4U50T2hyWqNJ={+Ln.=Hoi0wRSjեDTm-AaHҹĚ#_ǎ[Ф oZƇT̝M#C )RT'9hVb]WZ!I N|w@ ȋm\c'ʪeQ(-)ZOnۮd†OJ݌M3ΆcNGU$>xW ^UKۨ!RzߧJ q!_GC$rq= dW,zٵ+!ځj ._ ؋ߗ=/@}O,zTj gԲwURT181BU2nARdç1VM?#~fǏmg:#ZRY$_6~G`C}pGqX!o ndDG(K' "~>JŁ u- \˺ Gh8{JA#,_Vb4[])^mhGQz?;\ ?+Ɨ,D}F/.cjiW"jl-tYn\%塐7pQ/TA\p|uUŎ: Tm5\$m1n. xM3~PFə&)Qxc!˝ :Q%Vs Ŷeuft`Ig~|{MժrCsffբJ,eƢHj]rT5BXpB~ٗ&oޣH?Mno /p& 3DU aOzڤ cыq] cleGZmUN;)g*L "'=>-i۹?LOqADsDlsDA!<-oȠ5? is#H؜5J+dDhX{[=C43: !M}f +p8./J!:jpfC_*O feoe(Y Z<;3\maHi[8mtרѥRx6~vaNq& &E]KDT8*h x5NEn}i\4_>^wc..l%Bbz ?4 ^⦤$z~CY@$QZ9X0U-|l=*#E&j@hQ<L<-'Q."90' ޷ŒB0 [<{Ri$P͉ f`U=h4#_o ԘTl]bJ˗bh~ӃxaM "GmDE_`;WfqM>3Q[Pw:D%Z ~ٗeJ9QV9"(ځHVa/p]8zVB٠fսk׳s; ܕM_w_ś˛g\jc+QN-Fm-tAnd\9SYU/Tp}z88Okx q5UraCh0&X$O=Ը1y)l,w%|MaAHR*rĶ&`%-Ppҕ.TڼBēH m]ڳR.0V_lrk{|WfBo8KI)<9d{Z:w;$-`;ėSJTms l)u29JﴆcRw|͹\GXFil^0S2-4}wpgj sC!Uy2=:\?9BV0]U~%{c>f4`JQ4H9+3R_-V&Cտ:Ҿ(SK`}ƒw5H4C7JٲVmIz}߽O})LIgX h|9_mM ]F]-,>^wDEOFn~F=xW}GQ١dG]gP5uHQ\W۹yCTWW #;'&|5T!]ب/We,)Bh(p(՜":,+ԡd޾:jIZQY8֛OwCeP1~{O #S!l<>_[mʈ ziįf5^#+\GU$9(eXXKk{U5$%Н/ Gbi4K)vc q kը_S4/: 0:%^zCrr%Q>s!*vwW 0 4 G$fue㮭+(X Z20}k b>(مM>ZP^b
    Enjoying the preview?
    Page 1 of 1